Search

Your search keyword '"Liem AH"' showing total 46 results

Search Constraints

Start Over You searched for: Author "Liem AH" Remove constraint Author: "Liem AH"
46 results on '"Liem AH"'

Search Results

1. Ezetimibe added to statin therapy after acute coronary syndromes

4. Effect of metoprolol CR XL in chronic heart failure: Metoprolol CR XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

5. Early recognition of heart failure in patients with diabetes type 2 in primary care. A prospective diagnostic efficiency study. (UHFO-DM2).

6. Identifying genetic risk variants for coronary heart disease in familial hypercholesterolemia: an extreme genetics approach

7. Effects of a stepwise, structured LDL-C lowering strategy in patients post-acute coronary syndrome.

8. Indications for an early invasive strategy in NSTE-ACS patients.

9. Treatment patterns of non-ST-elevation acute coronary syndrome patients presenting at non-PCI centres in the Netherlands and possible logistical consequences of adopting same-day transfer to PCI centres: a registry-based evaluation.

10. Effect of a treat-to-target intervention of cardiovascular risk factors on subclinical and clinical atherosclerosis in rheumatoid arthritis: a randomised clinical trial.

11. 2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: comments from the Dutch ACS working group.

12. A Rapid (Differential) Effect of Rosuvastatin and Atorvastatin on High-Sensitivity Cardiac Troponin-I in Subjects With Stable Cardiovascular Disease.

13. Erythrocyte-bound apolipoprotein B in atherosclerosis and mortality.

14. 2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: comments from the Dutch ACS working group.

15. Leucocyte-bound apolipoprotein B in the circulation is inversely associated with the presence of clinical and subclinical atherosclerosis.

16. Health status of older patients with type 2 diabetes and screen-detected heart failure is significantly lower than those without.

17. Cost-effectiveness of screening strategies to detect heart failure in patients with type 2 diabetes.

18. Coronary leukocyte activation in relation to progression of coronary artery disease.

19. In vivo evidence for chylomicrons as mediators of postprandial inflammation.

20. Glucose-dependent leukocyte activation in patients with type 2 diabetes mellitus, familial combined hyperlipidemia and healthy controls.

21. Efficiently screening heart failure in patients with type 2 diabetes.

22. Statins for acute coronary syndrome.

23. Low high-density lipoprotein cholesterol is not a risk factor for recurrent vascular events in patients with vascular disease on intensive lipid-lowering medication.

24. Plasma triglyceride levels increase the risk for recurrent vascular events independent of LDL-cholesterol or nonHDL-cholesterol.

25. High prevalence of previously unknown heart failure and left ventricular dysfunction in patients with type 2 diabetes.

26. Statins for acute coronary syndrome.

27. Economic evaluation of ezetimibe combined with simvastatin for the treatment of primary hypercholesterolaemia.

28. Effect of increasing doses of Rosuvastatin and Atorvastatin on apolipoproteins, enzymes and lipid transfer proteins involved in lipoprotein metabolism and inflammatory parameters.

29. Evaluation of cholesterol lowering treatment of patients with familial hypercholesterolemia: a large cross-sectional study in The Netherlands.

30. RESPONSE study: Randomised Evaluation of Secondary Prevention by Outpatient Nurse SpEcialists: Study design, objectives and expected results.

31. Efficacy of statins in familial hypercholesterolaemia: a long term cohort study.

32. Lipidomic approach to evaluate rosuvastatin and atorvastatin at various dosages: investigating differential effects among statins.

33. Determinants of CRP level in statin-treated patients.

34. The efficacy of statin monotherapy uptitration versus switching to ezetimibe/simvastatin: results of the EASEGO study.

35. ApoB/A1 and LDL-C/HDL-C and the prediction of cardiovascular risk in statin-treated patients.

36. [Myocardial ischaemia as a result of treatment with capecitabine].

37. LDL-C/HDL-C ratio in subjects with cardiovascular disease and a low HDL-C: results of the RADAR (Rosuvastatin and Atorvastatin in different Dosages And Reverse cholesterol transport) study.

38. The contribution of classical risk factors to cardiovascular disease in familial hypercholesterolaemia: data in 2400 patients.

39. Enhancing reverse cholesterol transport/raising HDL cholesterol: new options for prevention and treatment of cardiovascular disease.

40. Efficacy of folic acid when added to statin therapy in patients with hypercholesterolemia following acute myocardial infarction: a randomised pilot trial.

41. Secondary prevention in coronary heart disease patients with low HDL: which options do we have?

42. Effect of fluvastatin on ischaemia following acute myocardial infarction: a randomized trial.

44. Apolipoprotein B and coronary artery disease in women: a cross-sectional study in women undergoing their first coronary angiography.

45. Addition of felodipine to metoprolol vs replacement of metoprolol by felodipine in patients with angina pectoris despite adequate beta-blockade. Results of the Felodipine ER and Metoprolol CR in Angina (FEMINA) Study. Working Group on Cardiovascular Research, The Netherlands (WCN).

46. Assessment of myocardial damage in patients with acute myocardial infarction by serial measurement of serum alpha-hydroxybutyrate dehydrogenase levels.

Catalog

Books, media, physical & digital resources